Shenzhen YHLO Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	464.97	490.59	1,251	478.85
Short-Term Investments	-	182.36	143.6	68.57	-
Trading Asset Securities	-	69.59	76.66	114.16	16.15
Cash & Short-Term Investments	633.63	716.93	710.85	1,433	495
Cash Growth	-11.62%	0.85%	-50.40%	189.56%	113.03%
Accounts Receivable	-	523.85	414.19	346.38	254.43
Other Receivables	-	54.23	48.11	66.2	21.48
Receivables	-	578.08	462.3	412.58	275.91
Inventory	-	670.77	634.5	569.54	363.81
Other Current Assets	-	45.98	43.08	79.72	43.34
Total Current Assets	-	2,012	1,851	2,495	1,178
Property, Plant & Equipment	-	1,735	1,371	1,044	672.07
Long-Term Investments	-	358.17	260.91	302.82	75.42
Goodwill	-	5.29	5.29	5.29	-
Other Intangible Assets	-	182.88	188.98	210.07	103.78
Long-Term Accounts Receivable	-	-	-	-	3.76
Long-Term Deferred Tax Assets	-	44.01	47.68	50.57	16.81
Long-Term Deferred Charges	-	26.97	43.12	36.15	22.87
Other Long-Term Assets	-	51	37.89	69.9	65.05
Total Assets	-	4,415	3,806	4,214	2,138
Accounts Payable	-	213.13	203.81	307.76	137.6
Accrued Expenses	-	164.42	145.99	211.11	54.88
Short-Term Debt	-	292.32	171.07	279.36	150.82
Current Portion of Long-Term Debt	-	23.8	-	-	-
Current Portion of Leases	-	1.84	1.07	5.05	4.73
Current Income Taxes Payable	-	4.59	13.27	75.73	12.27
Current Unearned Revenue	-	184.5	183.51	528.61	111.09
Other Current Liabilities	-	173.11	122.56	126.24	40.79
Total Current Liabilities	-	1,058	841.28	1,534	512.17
Long-Term Debt	-	585.44	381.89	183.9	73.26
Long-Term Leases	-	2.39	3.57	5.24	4.89
Long-Term Unearned Revenue	-	62.52	36.7	29.75	33.25
Long-Term Deferred Tax Liabilities	-	4.54	9.06	15.88	0.02
Other Long-Term Liabilities	-	0.74	-	-	-
Total Liabilities	-	1,713	1,273	1,769	623.59
Common Stock	-	570.27	568.13	567	405
Additional Paid-In Capital	-	480.36	432.24	389.51	525.03
Retained Earnings	-	1,692	1,546	1,447	595.8
Comprehensive Income & Other	-	14.38	13.53	13.84	-0.12
Total Common Equity	2,703	2,757	2,560	2,417	1,526
Minority Interest	-	-55.32	-26.27	28.1	-11.49
Shareholders' Equity	2,642	2,702	2,534	2,445	1,514
Total Liabilities & Equity	-	4,415	3,806	4,214	2,138
Total Debt	983.89	905.79	557.6	473.55	233.69
Net Cash (Debt)	-350.27	-188.86	153.25	959.74	261.31
Net Cash Growth	-	-	-84.03%	267.28%	-
Net Cash Per Share	-0.58	-0.33	0.27	1.69	0.48
Filing Date Shares Outstanding	754.06	570.27	568.13	567	567
Total Common Shares Outstanding	570.43	570.27	568.13	567	567
Working Capital	-	954.06	1,009	961.27	665.88
Book Value Per Share	4.74	4.83	4.51	4.26	2.69
Tangible Book Value	2,532	2,569	2,366	2,202	1,422
Tangible Book Value Per Share	4.44	4.50	4.16	3.88	2.51
Buildings	-	891.92	342.69	322.37	222.47
Machinery	-	1,370	1,069	817.66	582.7
Construction In Progress	-	168.82	460.54	256.9	96.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.